Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Elutia Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ELUT
Nasdaq
2836
https://elutia.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Elutia Inc
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1
- Apr 24th, 2024 8:05 pm
Elutia Full Year 2023 Earnings: Misses Expectations
- Mar 10th, 2024 12:07 pm
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
- Mar 7th, 2024 9:05 pm
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
- Feb 22nd, 2024 9:05 pm
Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants
- Feb 20th, 2024 3:37 pm
Elutia Regains Compliance with Nasdaq Listing Requirements
- Jan 10th, 2024 9:05 pm
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
- Dec 18th, 2023 1:00 pm
Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results
- Nov 13th, 2023 9:05 pm
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
- Nov 9th, 2023 1:30 pm
Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
- Nov 6th, 2023 9:05 pm
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
- Oct 18th, 2023 12:00 pm
Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference
- Sep 20th, 2023 12:30 pm
Elutia Announces Private Placement for Proceeds Up to $26 Million
- Sep 19th, 2023 12:36 pm
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
- Sep 18th, 2023 8:08 pm
Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Sep 8th, 2023 12:30 pm
Scroll